Access cutting-edge breast cancer treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Sponsor: Jazz Pharmaceuticals
Check if you qualify for this breast cancer clinical trial in Denver, CO
If you're searching for breast cancer treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.